FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200567858> ?p ?o ?g. }

• W4200567858 abstract "Infectious diseases account for the third most common cause of neonatal deaths. Globally, antibiotic resistance (ABR) has been increasingly challenging neonatal sepsis treatment, with 26 to 84% of gram-negative bacteria resistant to third-generation cephalosporins. In sub-Saharan Africa, limited evidence is available regarding the neonatal microbiology and ABR. To our knowledge, no studies have assessed neonatal bacterial infections and ABR in Central-African Republic (CAR). Therefore, this study aimed to describe the pathogens isolated and their specific ABR among patients with suspected antibiotic-resistant neonatal infection admitted in a CAR neonatal unit.This retrospective cohort study included neonates admitted in the neonatal unit in Bangui, CAR, from December 2018 to March 2020, with suspected antibiotic-resistant neonatal infection and subsequent blood culture. We described the frequency of pathogens isolated from blood cultures, their ABR prevalence, and factors associated with fatal outcome.Blood cultures were positive in 33 (26.6%) of 124 patients tested (17.9% for early-onset and 46.3% for late-onset infection; p = 0.002). Gram-negative bacteria were isolated in 87.9% of positive samples; with most frequently isolated bacteria being Klebsiella pneumoniae (39.4%), Escherichia coli (21.2%) and Klebsiella oxytoca (18.2%). All tested bacteria were resistant to ampicillin. Resistance to third-generation cephalosporins was observed in 100% of tested Klebsiella pneumoniae, 83.3% of isolated Klebsiella oxytoca and 50.0% of tested Escherichia coli. None of the tested bacteria were resistant to carbapenems. Approximately 85.7 and 77.8% of gram-negative tested bacteria were resistant to first-line (ampicillin-gentamicin) and second-line (third-generation cephalosporins) treatments, respectively. In hospital mortality, adjusted for blood culture result, presence of asphyxia, birth weight and sex was higher among neonates with positive blood culture (adjusted relative risk [aRR] = 2.32; 95% confidence interval [CI] = 1.17-4.60), male sex (aRR = 2.07; 95% CI = 1.01-4.26), asphyxia (aRR = 2.42; 95% CI = 1.07-5.47) and very low birth weight (1000-1499 g) (aRR = 2.74; 95% CI = 1.3-5.79).Overall, 77.8% of confirmed gram-negative neonatal infections could no longer effectively be treated without broad-spectrum antibiotics that are not routinely used in sub-Saharan Africa referral hospitals. Carbapenems should be considered an option in hospitals with surveillance and antibiotic stewardship." @default.
• W4200567858 created "2021-12-31" @default.
• W4200567858 creator A5000107759 @default.
• W4200567858 creator A5005642145 @default.
• W4200567858 creator A5046507675 @default.
• W4200567858 creator A5051735421 @default.
• W4200567858 creator A5059698819 @default.
• W4200567858 creator A5059737418 @default.
• W4200567858 creator A5061749844 @default.
• W4200567858 creator A5090162073 @default.
• W4200567858 date "2021-12-01" @default.
• W4200567858 modified "2023-10-18" @default.
• W4200567858 title "When first line treatment of neonatal infection is not enough: blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic" @default.
• W4200567858 cites W1137009663 @default.
• W4200567858 cites W1484101195 @default.
• W4200567858 cites W1983038970 @default.
• W4200567858 cites W2000795003 @default.
• W4200567858 cites W2019091990 @default.
• W4200567858 cites W2102478091 @default.
• W4200567858 cites W2121860179 @default.
• W4200567858 cites W2140353364 @default.
• W4200567858 cites W2158444099 @default.
• W4200567858 cites W2166266395 @default.
• W4200567858 cites W2206487910 @default.
• W4200567858 cites W2213615636 @default.
• W4200567858 cites W2297445500 @default.
• W4200567858 cites W2324411687 @default.
• W4200567858 cites W2341503511 @default.
• W4200567858 cites W2468260318 @default.
• W4200567858 cites W2495049384 @default.
• W4200567858 cites W2530713571 @default.
• W4200567858 cites W2596028842 @default.
• W4200567858 cites W2603962982 @default.
• W4200567858 cites W2753051611 @default.
• W4200567858 cites W2768745408 @default.
• W4200567858 cites W2775233367 @default.
• W4200567858 cites W2810926218 @default.
• W4200567858 cites W2907198977 @default.
• W4200567858 cites W2910024368 @default.
• W4200567858 cites W2923627361 @default.
• W4200567858 cites W2940142875 @default.
• W4200567858 cites W2969858855 @default.
• W4200567858 cites W2972945544 @default.
• W4200567858 cites W2990203740 @default.
• W4200567858 cites W2998853022 @default.
• W4200567858 cites W4255232901 @default.
• W4200567858 doi "https://doi.org/10.1186/s12887-021-02911-w" @default.
• W4200567858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34903185" @default.
• W4200567858 hasPublicationYear "2021" @default.
• W4200567858 type Work @default.
• W4200567858 citedByCount "3" @default.
• W4200567858 countsByYear W42005678582022 @default.
• W4200567858 countsByYear W42005678582023 @default.
• W4200567858 crossrefType "journal-article" @default.
• W4200567858 hasAuthorship W4200567858A5000107759 @default.
• W4200567858 hasAuthorship W4200567858A5005642145 @default.
• W4200567858 hasAuthorship W4200567858A5046507675 @default.
• W4200567858 hasAuthorship W4200567858A5051735421 @default.
• W4200567858 hasAuthorship W4200567858A5059698819 @default.
• W4200567858 hasAuthorship W4200567858A5059737418 @default.
• W4200567858 hasAuthorship W4200567858A5061749844 @default.
• W4200567858 hasAuthorship W4200567858A5090162073 @default.
• W4200567858 hasBestOaLocation W42005678581 @default.
• W4200567858 hasConcept C104317684 @default.
• W4200567858 hasConcept C126322002 @default.
• W4200567858 hasConcept C187212893 @default.
• W4200567858 hasConcept C2775953899 @default.
• W4200567858 hasConcept C2776021129 @default.
• W4200567858 hasConcept C2777058267 @default.
• W4200567858 hasConcept C2777091541 @default.
• W4200567858 hasConcept C2778050735 @default.
• W4200567858 hasConcept C2778384902 @default.
• W4200567858 hasConcept C2779116282 @default.
• W4200567858 hasConcept C2779473907 @default.
• W4200567858 hasConcept C501593827 @default.
• W4200567858 hasConcept C547475151 @default.
• W4200567858 hasConcept C55493867 @default.
• W4200567858 hasConcept C64778159 @default.
• W4200567858 hasConcept C71924100 @default.
• W4200567858 hasConcept C86803240 @default.
• W4200567858 hasConcept C89423630 @default.
• W4200567858 hasConcept C94665300 @default.
• W4200567858 hasConceptScore W4200567858C104317684 @default.
• W4200567858 hasConceptScore W4200567858C126322002 @default.
• W4200567858 hasConceptScore W4200567858C187212893 @default.
• W4200567858 hasConceptScore W4200567858C2775953899 @default.
• W4200567858 hasConceptScore W4200567858C2776021129 @default.
• W4200567858 hasConceptScore W4200567858C2777058267 @default.
• W4200567858 hasConceptScore W4200567858C2777091541 @default.
• W4200567858 hasConceptScore W4200567858C2778050735 @default.
• W4200567858 hasConceptScore W4200567858C2778384902 @default.
• W4200567858 hasConceptScore W4200567858C2779116282 @default.
• W4200567858 hasConceptScore W4200567858C2779473907 @default.
• W4200567858 hasConceptScore W4200567858C501593827 @default.
• W4200567858 hasConceptScore W4200567858C547475151 @default.
• W4200567858 hasConceptScore W4200567858C55493867 @default.
• W4200567858 hasConceptScore W4200567858C64778159 @default.
• W4200567858 hasConceptScore W4200567858C71924100 @default.
• W4200567858 hasConceptScore W4200567858C86803240 @default.
• W4200567858 hasConceptScore W4200567858C89423630 @default.

• next